IRIS
ROSSI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.188
Totale 1.188
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.188
Totale 1.188
Salva come PNG Salva come JPEG
Città #
Genova 578
Rapallo 347
Genoa 252
Bordighera 11
Totale 1.188
Salva come PNG Salva come JPEG
Nome #
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 109
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 103
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study 87
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 74
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer 73
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 71
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 66
Vinflunine for the treatment of non-small cell lung cancer 63
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 56
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer 52
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine 50
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds 50
Radiomic detection of EGFR mutations in NSCLC 44
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer 42
Liquid biopsy in non-small cell lung cancer: Highlights and challenges 40
Radiomic-based diagnostics in oncology: challenges toward clinical practice 37
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics 32
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors? 32
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 30
Novel emerging molecular targets in non-small cell lung cancer 30
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 27
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 24
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 23
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 16
Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer management 15
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 11
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer 3
Totale 1.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.418
article - articoli 6.418
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 5 5
2019/2020155 4 9 5 12 16 21 19 12 20 21 13 3
2020/2021245 3 4 3 87 47 3 6 25 26 28 5 8
2021/2022221 19 8 6 10 13 18 1 39 27 26 19 35
2022/2023390 22 27 5 39 88 60 4 25 55 10 53 2
2023/2024233 4 21 7 31 23 51 35 25 14 22 0 0
Totale 1.260